skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
HPV 16 E7:86-93 Peptide Vaccine (Code C38761)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: HPV 16 E7:86-93 Peptide Vaccine

Definition: A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7.

Display Name: HPV 16 E7:86-93 Peptide Vaccine

Label: HPV 16 E7:86-93 Peptide Vaccine

NCI Thesaurus Code: C38761 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0879333  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
E7(86-93) Lipopeptide
HPV 16 E7:86-93 Peptide Vaccine
HPV 16E7 86-93 Lipopeptide Vaccine
HPV-16E7 (86-93)

External Source Codes: 
PDQ Closed Trial Search ID 43625
PDQ Open Trial Search ID 43625 (check for NCI PDQ open clinical trial info)
UMLS CUI C0879333

Other Properties:
     Name Value (qualifiers indented underneath)
code C38761
Contributing_Source CTRP
Legacy_Concept_Name HPV_16E7_86-93_Lipopeptide_Vaccine
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom